pneumonia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Being aged 18 years or above; - Having a working diagnosis of CAP at the emergency department with the presence of at least two of the clinical criteria (below)* or one clinical criterion and radiological evidence of CAP, with no other explanation for the signs and symptoms; - Requiring hospitalisation to a non-ICU ward via the ER., * Clinical criteria include: * New or worsened coughing; * Production of purulent sputum or change in character of sputum; * Temperature > 38°C or 10×10^9 cells/L or 15% bands * C-reactive protein level > 20 breaths per minute), or hypoxaemia (arterial pO2
Exclusion criteria
Exclusion criteria: - Hospitalisation for two or more days in the last 14 days; - Residence in a long-term care facility in the last 14 days; - History of cystic fibrosis; - Severe immunodeficiency, defined as having one or more of the following criteria: * HIV infection with a last CD4 count of 3 months; * History of receiving an organ or bone marrow transplant; * Using immunosuppressive therapy. This includes corticosteroid treatment only when dosage is high (>0,5mg/kg/day) for a longer period of time (>14 days). * History of primary immunocompromising conditions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary effectiveness outcome is days of therapy of broad-spectrum antibiotics. The primary safety outcome, on which the sample size is calculated, is 90-day all-cause mortality. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Number of days of treatment with any antibiotics during index admission, including antibiotic prescriptions provided at discharge; - Number of days hospitalized during the index hospitalization; - Occurrence of ICU admission during the index hospitalization; - Occurrence of in-hospital mortality during the index hospitalization; - Occurrence of readmissions after the index admission within 30 days of the index admission; - Time from admission to availability of the low-dose CT results; - Time from admission to provision of a treatment recommendation following the low-dose CT results; - Proportion of patients changing the diagnosis based on low-dose CT results; - Time from admission to change in diagnosis based on low-dose CT results; - Time from presenting at the ER to availability of the PoC-PCR test results; - Time from presenting at the ER to provision of a treatment recommendation following the PoC-PCR test results; - Proportion of patients changing from empirical to or started on targeted antibiotic treatment based on PoC-PCR results; - Proportion of patients stopping empirical antibiotic treatment early (within 72 hours) based on PoC-PCR results; - Time from admission to targeted antibiotic treatment or early termination based on the PoC-PCR results; | — |
Countries
The Netherlands